Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Return on Equity: 2011-2025

Historic Return on Equity for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to -21.72%.

  • Lifecore Biomedical's Return on Equity fell 2191.00% to -21.72% in Q2 2025 from the same period last year, while for May 2025 it was -21.72%, marking a year-over-year decrease of 2191.00%. This contributed to the annual value of -6.12% for FY2025, which is 688.00% down from last year.
  • Per Lifecore Biomedical's latest filing, its Return on Equity stood at -21.72% for Q2 2025, which was down 411.06% from -4.25% recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical's Return on Equity peaked at 4.22% during Q4 2023, and registered a low of -21.72% during Q2 2025.
  • Moreover, its 3-year median value for Return on Equity was -1.94% (2023), whereas its average is -3.01%.
  • Per our database at Business Quant, Lifecore Biomedical's Return on Equity skyrocketed by 511bps in 2023 and then tumbled by 2,191bps in 2025.
  • Over the past 5 years, Lifecore Biomedical's Return on Equity (Quarterly) stood at -0.31% in 2021, then crashed by 57bps to -0.89% in 2022, then soared by 511bps to 4.22% in 2023, then plummeted by 804bps to -3.81% in 2024, then tumbled by 2,191bps to -21.72% in 2025.
  • Its last three reported values are -21.72% in Q2 2025, -4.25% for Q1 2025, and -3.81% during Q4 2024.